Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis
Editor Note: For more information about this release, please scroll to bottom.
NEW YORK, October 31, 2014
AMAG Pharmaceuticals Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2014
New white paper documents Lilly's philanthropic effort to expand access to multidrug-resistant tuberculosis medicines
Plans to Payout Approximately 60 Percent of Adjusted Net Income on Average to Shareholders Through 2018
QUEENSLAND, Australia, Oct.